Vitamin K AntagonISt, Factor Xa Inhibitor or No Anticoagulation in Atrial Fibrillation and DIalytic End-stage Renal DiseasE (VISIONAIRE)
- Status
- RECRUITING
- Phase
- PHASE4
Clinical Trials Related to Daiichi Sankyo
Related studies linked through entity extraction aliases.
HER-TEMPO - Real World Treatment-related Outcomes on T-DXd in Canada
- Status
- COMPLETED
- Phase
- N/A
A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
- Status
- RECRUITING
- Phase
- PHASE3
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Dose-Expansion Modular Study To Explore the Safety, Tolerability, and Anti-tumor Activity of HER3- DXd Monotherapy and Combinations in Patients With Inoperable Advanced Breast Cancer (ABC) After Progression on T-DXd
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Medical Access Program for Datopotamab Deruxtecan in EGFRm NSCLC Patients
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
CHIP-AML22/Quizartinib: Quizartinib + Chemotherapy in Newly Diagnosed Pediatric FLT3-ITD+ and NPM1wt AML Patients
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Valemetostat Tosylate in Combination With DXd ADCs in Subjects With Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Whole Body HER3 Quantification With Radiolabelled Patritumab Deruxtecan (HER3-DXd) PET/CT
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Assess the Effectiveness of Trastuzumab Deruxtecan in Chinese Breast Cancer Patients (REFRESH)
- Status
- RECRUITING
- Phase
- N/A
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE3
DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Provide Continued Access to and Assess Long-Term Safety of the Study Drug(s)
- Status
- RECRUITING
- Phase
- PHASE3
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor-low/HER2-negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Thromboembolic Risk Assessment in Patients Admitted With Acute Medical Diseases to Conventional and At Home Hospitalization
- Status
- RECRUITING
- Phase
- N/A
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
- Status
- RECRUITING
- Phase
- PHASE3